Jackson Grant Investment Advisers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-212
Closed -$20K 288
2021
Q3
$20K Hold
212
0.01% 287
2021
Q2
$26K Sell
212
-188
-47% -$22.4K 0.01% 270
2021
Q1
$53K Hold
400
0.02% 189
2020
Q4
$53K Buy
+400
New +$48.4K 0.03% 176

Other funds holding EXAS

Jackson Grant Investment Advisers's EXAS Position: Q4 2021 in Review

Jackson Grant Investment Advisers sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 212 shares — an estimated $20K sold.

Jackson Grant Investment Advisers first reported a position in EXAS in Q4 2020 and held it in 4 quarters. The position peaked at $53K in Q1 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Jackson Grant Investment Advisers reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 212 Exact Sciences shares in Q4 2021, an estimated $20K.
  • Jackson Grant Investment Advisers first reported a position in Exact Sciences in Q4 2020 and held it in 4 quarters.
  • Jackson Grant Investment Advisers's Exact Sciences position peaked at $53K in Q1 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Jackson Grant Investment Advisers's 13F filing for Q4 2021, filed 24 Jan 2022.